The estimated Net Worth of Jane E Kiernan is at least $1.27 Milhão dollars as of 29 March 2022. Ms. Kiernan owns over 5,250 units of Axonics Inc stock worth over $521,936 and over the last 6 years she sold AXNX stock worth over $317,625. In addition, she makes $429,369 as Independent Director at Axonics Inc.
Jane has made over 2 trades of the Axonics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 5,250 units of AXNX stock worth $317,625 on 29 March 2022.
The largest trade she's ever made was exercising 14,167 units of Axonics Inc stock on 5 August 2021 worth over $352,475. On average, Jane trades about 2,157 units every 26 days since 2019. As of 29 March 2022 she still owns at least 7,594 units of Axonics Inc stock.
You can see the complete history of Ms. Kiernan stock trades at the bottom of the page.
Jane E. Kiernan serves as Independent Director of the Company. Ms. Kiernan has over 30 years of executive and management leadership in health care with both public and private companies. Ms. Kiernan is a co-founder of K2 Biotechnology Ventures, an organization engaged in developing and commercializing university and medical center innovations in partnership with venture capital, health care corporations and philanthropic health care foundation partners. From 2010 to 2017, Ms. Kiernan served as the Chief Executive Officer of Salter Labs, a manufacturer of specialty medical devices. From 2006 to 2011, Ms. Kiernan served on the board of directors and as Chair of the audit committee of American Medical Systems Holdings Inc. prior to it being acquired by Endo Health Solutions Inc., formerly Endo Pharmaceuticals Holdings Inc., a subsidiary of Endo International plc. From 2001 to 2010, Ms. Kiernan held executive and general management positions with Baxter Healthcare Corporation. Prior to 2001, she held corporate and line management roles in finance, strategy, marketing, and operations with both Baxter Healthcare Corporation and Allegiance Healthcare Corporation. As a community leader, Ms. Kiernan serves on the board of directors of Ryan Banks Academy, an urban boarding school in Chicago, and has served as committee Chair and on the board of directors of the American Red Cross of Greater Chicago. In addition, she is a past president of the Healthcare Businesswomen’s Association, Chicago Chapter. Ms. Kiernan holds a B.S. in business from Southern Methodist University.
As the Independent Director of Axonics Inc, the total compensation of Jane Kiernan at Axonics Inc is $429,369. There are 12 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of $6,147,640.
Jane Kiernan is 59, she's been the Independent Director of Axonics Inc since 2019. There are 5 older and 16 younger executives at Axonics Inc. The oldest executive at Axonics Inc is Nancy Snyderman, 68, who is the Independent Director.
Jane's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.
Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik, eGeoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Axonics Inc executives and other stock owners filed with the SEC include: